about
An immune defect causing dominant chronic mucocutaneous candidiasis and thyroid disease maps to chromosome 2p in a single family.A homozygous CARD9 mutation in a family with susceptibility to fungal infectionsInterleukin 17-Mediated Host Defense against Candida albicansIL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicansMucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapyIdentification of airborne microbiota in selected areas in a health-care setting in South AfricaHost responses to Candida albicans: Th17 cells and mucosal candidiasis.The role of the IL-12 cytokine family in directing T-cell responses in oral candidosis.Successful treatment of chronic mucocutaneous candidiasis caused by azole-resistant Candida albicans with posaconazole.Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis.Hosting infection: experimental models to assay Candida virulenceGenetic analysis of innate immunity in resistance to Candida albicans.Immunophenotypic characterisation of peripheral blood lymphocytes in autoimmune polyglandular syndrome type 1: clinical study and review of the literature.New approaches in the development of a vaccine for mucosal candidiasis: progress and challengesThe Extended Clinical Phenotype of 26 Patients with Chronic Mucocutaneous Candidiasis due to Gain-of-Function Mutations in STAT1Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis.Clinical features of Candidiasis in patients with inherited interleukin 12 receptor β1 deficiency.Chronic mucocutaneous candidiasis disease associated with inborn errors of IL-17 immunity.Simple diagnosis of STAT1 gain-of-function alleles in patients with chronic mucocutaneous candidiasisChapter 8: Fungal infections in immunocompromised patients.Novel strategies for the prevention and treatment of Candida infections: the potential of immunotherapy.Inborn errors of mucocutaneous immunity to Candida albicans in humans: a role for IL-17 cytokines?Candida infections in non-neutropenic children after the neonatal period.Ocular involvement in primary immunodeficiency diseases.Staphylococcus aureus Colonization: Modulation of Host Immune Response and Impact on Human Vaccine Design.Chronic Candidiasis in Children.Deregulated production of protective cytokines in response to Candida albicans infection in patients with chronic mucocutaneous candidiasis.Differential role of NK cells against Candida albicans infection in immunocompetent or immunocompromised mice.Congenital cutaneous candidiasis in two full-term infants.Microsecond pulsed magnetic field improves efficacy of antifungal agents on pathogenic microorganisms.Modulation of the Fungal-Host Interaction by the Intra-Species Diversity of C. albicans.Patient-centred screening for primary immunodeficiency: a multi-stage diagnostic protocol designed for non-immunologists.Recurrent candidal intertrigo: challenges and solutions.Langerin+ DCs regulate innate IL-17 production in the oral mucosa during Candida albicans-mediated infection.What Is the Cause of the Chronic Erythematous Scaling Plaques on This 22-Month-Old Girl and Her Family?Chronic mucocutaneous candidiasis and oesophageal cancer
P2860
Q24533389-D3661005-C77A-4EC3-8FEB-254CC0874039Q24658090-12628892-7A3B-4C6E-8080-04D596D24316Q26798127-C8F3D682-FBE2-466E-888F-7AB729E280ECQ26799351-FD3289E1-F8F1-4125-99AD-DED2F2B5C988Q27010562-95B87087-4772-4794-B07E-17E7778D91AAQ33593681-83490829-9E91-4B3D-B2AB-949B36AD6B21Q33941537-35F43F01-93DB-4C00-8910-9A7B83EE9BA4Q34235746-39047210-DC2C-4250-89D7-7CDDEE621772Q34415094-2C961498-A3B1-48E5-9AE1-94D8539041E8Q35144610-BA208393-7024-4EAB-88A5-535C3893129BQ35659934-5BFDF5BE-95A5-4A4C-9476-2037C0140190Q35889577-315281AE-8812-4E73-8FB5-F5FB554DEBD5Q36063773-D4F298EC-AF9F-44EB-A9DA-A51205462C10Q36158337-D7F0FE41-A639-4A4D-A930-F0004C39B5A3Q36480090-1E27D3C0-6133-471E-B648-D42D18FBC483Q36512728-85D5C77B-2EDC-48D0-B908-BB2A9491E94DQ37411703-5C7FA51F-231C-4737-B4D7-3DD0018E3EA0Q37538514-72F3326A-91A5-4CF5-9310-7323D29AA9C4Q37644982-1C643095-93BA-4805-A643-EB60FEB27CC6Q37704244-D2A4A2C5-D0AF-43E0-A1EA-5CE71A3DDB77Q37763270-19B6B7DE-84E9-4236-9809-745FF196436BQ37776837-4BAFE78A-033B-443A-8BC9-5B67AF20D843Q37942655-12511F4C-D06F-42DD-9066-26305F350421Q38167633-9762C66F-AE1E-48EB-B804-03C094B49F1AQ38177271-0CA0C26B-6008-42FB-80E5-A53374A284AFQ39254071-5B1DE7B5-D475-4552-B1B3-38024FB98890Q39913037-8525A3A7-3DD6-457A-AA8B-52EAFF903280Q42216368-F79140FF-5F5E-48A5-BDA0-65CBE6F8CEB7Q46277521-B91D4969-3667-40D7-9B7D-FC610484695AQ46920534-7ED13783-0C57-4CC4-9C0E-98BED78EA5EEQ48226967-07D2F43B-ACCB-4AC6-813F-562D7FE2AABFQ51936361-B5E029B8-9B2B-477E-A657-D9ACC0C5F183Q54944000-F42CF773-2181-4357-B2FD-E288836AB18AQ55286511-215B275A-658B-49D3-B038-FE2ED3A1D95EQ55396669-AE0233FA-FD9C-4143-A0F4-4116451BB6EEQ56837277-42E7BF3C-8E66-421C-AC71-4D021A7D98CA
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Chronic mucocutaneous candidiasis.
@ast
Chronic mucocutaneous candidiasis.
@en
Chronic mucocutaneous candidiasis.
@nl
type
label
Chronic mucocutaneous candidiasis.
@ast
Chronic mucocutaneous candidiasis.
@en
Chronic mucocutaneous candidiasis.
@nl
prefLabel
Chronic mucocutaneous candidiasis.
@ast
Chronic mucocutaneous candidiasis.
@en
Chronic mucocutaneous candidiasis.
@nl
P1476
Chronic mucocutaneous candidiasis.
@en
P2093
Kirkpatrick CH
P304
P356
10.1097/00006454-200102000-00017
P577
2001-02-01T00:00:00Z